Based on this, their further research identified the relationship between miR-34 and PDGFR-α/β that PDGFR-α/β was targetly regulated by miR-34, which provided a therapeutic target for the treatment of non-small-cell lung cancer. This evidence concerns the gene PDGFRA and non-small cell lung carcinoma.